Related Experiment Video
Updated: Jun 5, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Response predictors to treatment with pegylated interferon in chronic hepatitis B
Paulo Roberto Abrão Ferreira1, Simone de Barros Tenore
1Discipline of Infectious Diseases of UNIFESP, São Paulo - Brazil. ferreira@gmail.com
Abstract:
The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in patients presenting poor treatment tolerance. This review discusses the treatment response predictors usefulness, with emphasis on ALT, quantitative HBsAg and HBeAg, quantitative HBV-DNA and HBV genotype.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Viral Hepatitis I: Introduction

